- Home
- ANEB vs GNS Comparison
ANEB vs GNS Comparison
Compare ANEB & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANEB | GNS |
|---|---|---|
| Founded | 2020 | 2002 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.0M | 54.4M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ANEB | GNS |
|---|---|---|
| Price | $1.07 | $0.59 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 72.6K | ★ 711.3K |
| Earning Date | 02-13-2026 | 09-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,749,894.00 |
| Revenue This Year | N/A | $82.78 |
| Revenue Next Year | N/A | $85.90 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.90 | $0.21 |
| 52 Week High | $3.42 | $1.92 |
Technical Indicators
Market Signals| Indicator | ANEB | GNS |
|---|---|---|
| Relative Strength Index (RSI) | 27.62 | 40.17 |
| Support Level | $1.01 | $0.56 |
| Resistance Level | $1.12 | $0.62 |
| Average True Range (ATR) | 0.08 | 0.03 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 31.82 | 24.09 |
Price Performance
Historical ComparisonAbout ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education, which involves entrepreneur education, management consultancy, and business development tools; and Campus, consisting of resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America. The company derives maximum revenue from Europe/Middle East/Africa.